Medical - Instruments & Supplies industry analysis: EL7 Score and the best stocks ranked by value, profitability, and momentum.
70 of 151
P/E 33.0 vs period average 37.2 Cheaper than its history
Ranked among 25 stocks with a market cap above $500M. Smaller companies are excluded from the ranking.
Rank | Company | Price | P/E | Value | Growth | Quality | EL7 Score |
|---|---|---|---|---|---|---|---|
| 1/25 | ![]() | $87.45 | 10.7 | 90 | 43 | 73 | 93 |
| 2/25 | ![]() | $80.59 | 28.1 | 44 | 81 | 88 | 81 |
| 3/25 | ![]() | $25.55 | 44.1 | 83 | 53 | 59 | 79 |
| 4/25 | ![]() | $86.36 | 35.5 | 56 | 70 | 68 | 77 |
| 5/25 | ![]() | $177.85 | 53.6 | 74 | 41 | 65 | 74 |
| 6/25 | ![]() | $346.23 | 44.3 | 29 | 33 | 55 | 73 |
| 7/25 | ![]() | $53.91 | 18.4 | 91 | 66 | 77 | 66 |
| 8/25 | ![]() | $165.18 | 223.2 | 11 | 61 | 50 | 64 |
| 9/25 | ![]() | $369.15 | 42.1 | 30 | 83 | 86 | 63 |
| 10/25 | ![]() | $156.48 | 131.5 | 66 | 31 | 48 | 61 |
Score = market-cap-weighted percentile rank of the sector stocks vs the whole market (0-100). Higher = stronger.
Score = market-cap-weighted percentile rank of the sector stocks vs the whole market (0-100). Higher = stronger.
Insider purchases in the sector's stocks
Funds that track the sector and each fund's exposure to it.
Fund | Exposure | Assets | Expense |
|---|---|---|---|
| IBBiShares Biotechnology ETF | 100.0% | $10B | 0.44% |
| VHTVanguard Health Care ETF | 100.0% | $21B | 0.09% |
| IHIiShares U.S. Medical Devices ETF | 99.7% | $3B | 0.37% |
| XLVState Street Health Care Select Sector SPDR ETF | 99.2% | $43B | 0.08% |
The percentage is the sector's share of the fund's assets, per the latest available data.
Upgrades and downgrades on the sector's stocks